<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><description>医药行业</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 07 Apr 2021 10:13:27 +0800</pubDate><image><url>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</url><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Alloy Therapeutics完成7500万美元C轮融资，推进协同生物技术生态系统</title><link>https://mp.weixin.qq.com/s/7VZboqlkkxrmtpMWkyqvLw</link><description></description><content:encoded><![CDATA[Alloy Therapeutics完成7500万美元C轮融资，推进协同生物技术生态系统]]></content:encoded><pubDate>Wed, 07 Apr 2021 09:26:24 +0800</pubDate></item><item><title>新锐|英诺湖医药完成3亿元Pre-A轮融资！</title><link>https://mp.weixin.qq.com/s/CY5mGj5fQF6aL1Vcw-uLtQ</link><description></description><content:encoded><![CDATA[新锐|英诺湖医药完成3亿元Pre-A轮融资！]]></content:encoded><pubDate>Wed, 07 Apr 2021 09:26:24 +0800</pubDate></item><item><title>Cellphire Therapeutics完成1500万美元A轮融资</title><link>https://mp.weixin.qq.com/s/gGLk-EOyjnKkSc9idEQETw</link><description></description><content:encoded><![CDATA[Cellphire Therapeutics完成1500万美元A轮融资]]></content:encoded><pubDate>Wed, 07 Apr 2021 09:26:24 +0800</pubDate></item><item><title>数字基因组工程平台Inscripta完成1.5亿美元E轮融资</title><link>https://mp.weixin.qq.com/s/zndRSEvTWjV2DWtjSV4Ucw</link><description></description><content:encoded><![CDATA[数字基因组工程平台Inscripta完成1.5亿美元E轮融资]]></content:encoded><pubDate>Wed, 07 Apr 2021 09:26:24 +0800</pubDate></item><item><title>吉凯基因和天境生物合作开发多种双特异性抗体</title><link>https://mp.weixin.qq.com/s/D-ecEfvrWww5nvnasOCfkA</link><description></description><content:encoded><![CDATA[吉凯基因和天境生物合作开发多种双特异性抗体]]></content:encoded><pubDate>Wed, 07 Apr 2021 09:26:24 +0800</pubDate></item><item><title>新锐|Volastra完成4400万美元种子轮融资，开发预防癌症转移新药</title><link>https://mp.weixin.qq.com/s/_Q6XWBQoKl69hhSuu-wkXg</link><description></description><content:encoded><![CDATA[新锐|Volastra完成4400万美元种子轮融资，开发预防癌症转移新药]]></content:encoded><pubDate>Wed, 07 Apr 2021 09:26:24 +0800</pubDate></item><item><title>Mineralys Therapeutics完成4000万美元A轮融资</title><link>https://mp.weixin.qq.com/s/sZ9n8eHCt-BMjTPOoxySTQ</link><description></description><content:encoded><![CDATA[Mineralys Therapeutics完成4000万美元A轮融资]]></content:encoded><pubDate>Wed, 07 Apr 2021 09:26:24 +0800</pubDate></item><item><title>重磅！Sorrento宣布和艾森生物达成合并协议，总额可达4.88亿美元</title><link>https://mp.weixin.qq.com/s/XUOKMKHHOlNjczm5s9lcXw</link><description></description><content:encoded><![CDATA[重磅！Sorrento宣布和艾森生物达成合并协议，总额可达4.88亿美元]]></content:encoded><pubDate>Tue, 06 Apr 2021 10:06:49 +0800</pubDate></item><item><title>OncoResponse完成4060万美元C轮融资</title><link>https://mp.weixin.qq.com/s/nd4dAwZkbNkDbFUsvWm0kw</link><description></description><content:encoded><![CDATA[OncoResponse完成4060万美元C轮融资]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>BD交易|AffaMed Therapeutics与SIFI宣布成立合资公司</title><link>https://mp.weixin.qq.com/s/Sv6e-LyrhgjGBK93l6I9Zg</link><description></description><content:encoded><![CDATA[BD交易|AffaMed Therapeutics与SIFI宣布成立合资公司]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>Entrada Therapeutics完成1.16亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/FJXuJi_8FYKKi7nDeee4_g</link><description></description><content:encoded><![CDATA[Entrada Therapeutics完成1.16亿美元B轮融资]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>新锐|1亿美元B轮融资，开发突破性遗传医学的CRISPR平台和管线</title><link>https://mp.weixin.qq.com/s/KBCc59ZfAXQiwDt_BI38Dw</link><description></description><content:encoded><![CDATA[新锐|1亿美元B轮融资，开发突破性遗传医学的CRISPR平台和管线]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>CirrusMD完成2000万美元C轮融资</title><link>https://mp.weixin.qq.com/s/PI5_ABJUIAixOf37k685YA</link><description></description><content:encoded><![CDATA[CirrusMD完成2000万美元C轮融资]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>前默沙东高管加入Flagship Pioneering孵化的AI新锐公司担任CEO</title><link>https://mp.weixin.qq.com/s/G6ffgUYEqawMes7nXsen7A</link><description></description><content:encoded><![CDATA[前默沙东高管加入Flagship Pioneering孵化的AI新锐公司担任CEO]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>B轮融资1.06亿美元，SNÅP平台开发针对肿瘤获得性耐药的新型疗法</title><link>https://mp.weixin.qq.com/s/bRg_e7r6Ripz6diQCzbP1w</link><description></description><content:encoded><![CDATA[B轮融资1.06亿美元，SNÅP平台开发针对肿瘤获得性耐药的新型疗法]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>新锐！CD46抗体偶联新药（ADC）公司完成4000万美元A轮融资</title><link>https://mp.weixin.qq.com/s/qMz_K2YImz2zn9AtOl6LxQ</link><description></description><content:encoded><![CDATA[新锐！CD46抗体偶联新药（ADC）公司完成4000万美元A轮融资]]></content:encoded><pubDate>Thu, 01 Apr 2021 14:24:27 +0800</pubDate></item><item><title>ADC平台公司Pyxis Oncology完成1.52亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/q5KbBu7-WJigJtPQrN0fJA</link><description></description><content:encoded><![CDATA[ADC平台公司Pyxis Oncology完成1.52亿美元B轮融资]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>Flagship孵化的Omega Therapeutics完成1.26亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/jlfxRSwqYa4dbZ9roNhhLg</link><description></description><content:encoded><![CDATA[Flagship孵化的Omega Therapeutics完成1.26亿美元C轮融资]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>AffaMed Therapeutics完成1.7亿美元B轮融资，清池资本领投！</title><link>https://mp.weixin.qq.com/s/jyXswhay5NQIPF1f2dEYQg</link><description></description><content:encoded><![CDATA[AffaMed Therapeutics完成1.7亿美元B轮融资，清池资本领投！]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item><item><title>Immune-Onc完成7300万美元B1/B2轮融资，海松资本领投！</title><link>https://mp.weixin.qq.com/s/I8jZpPdm3V6_8oAOHHvZRw</link><description></description><content:encoded><![CDATA[Immune-Onc完成7300万美元B1/B2轮融资，海松资本领投！]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:59:39 +0800</pubDate></item></channel></rss>